Today’s top gainers include the company Merck & Co. Inc. (NYSE:MRK) which is in the industry Drug Manufacturers – Major, gaining 7.30% today. In the last week its performance is -1.01%, and 7.81% for the past quarter. Currently, Merck & Co. Inc., MRK has a target price of 62.05, so today’s gain of 7.30% is a significant step towards its target price. The GAP today is therefore 7.61%.
Merck & Co. Inc. (NYSE:MRK), has a market cap of 159474.71, and is based in USA. Insider ownership is at 0.04%, and institutional ownership is 75.00%.
At the current price of 62.06, it has a dividend yield of 3.18%, and its target price is 62.05. This is with a profit margin of 13.00%, and total debt/equity of *TBA. Merck & Co. Inc. (NYSE:MRK) has a P/E of 35.38, as well as a forward P/E of 15.43.
With a current EPS of 1.64, and a forecasted EPS growth for next year at 0.78%,Merck & Co. Inc. (NYSE:MRK) has had a EPS growth for the past five years at 41.50%. For the next five years EPS growth is projected to be 5.21%.
Performance for the year is 1.25%. Since its IPO date on 1/2/1970, the total performance to date is 11.36%.
Volume today for Merck & Co. Inc. (NYSE:MRK), is 41588932, while its average volume is 8687.76. Whilst the total gain today was 7.30%, it did have a day high of 3.52%.
Volatility for this week has been at 1.22%, and 1.13% for the month. The 52-week low for Merck & Co. Inc., MRK has been 40.53%, while the 52-week-high has reached 3.52%.
Looking at its return of investments, which is 6.40%, and its return on assets is *TBA. Merck & Co. Inc. (NYSE:MRK) has an operating margin of 18.10%. With a sales growth of 0.60% quarter over quarter. Bearing in mind that Merck & Co. Inc., MRK is in the sector Healthcare, its long-term debt/equity is *TBA, and has a current ratio of *TBA and *TBA for quick ratio.
So what is the value of Merck & Co. Inc.? Well its PEG is 6.79, and the P/S is 4.05, along with a P/B of 3.66. Meanwhile it has a p/cash of *TBA.